Chemical Structure (Norepinephrine Bitartrate Injection Usp 1)
Norepinephrine Bitartrate Injection
Product Images NDC 0143-9318
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 0143-9318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Plb191 (Norepinephrine Bitartrate Injection Usp 2)
Norepinephrine Bitartrate Injection, USP is an intravenous infusion-only medication that is supplied in a 4L single-dose vial. Each mL contains norepinephrine bitartrate that is equal to 1 mg of norepinephrine base. This medication needs to be diluted before use and should be protected from light. The medication contains sulfates. However, there is not enough information available in the text to provide a useful description.*
Shelfpack June 2018 2 (Norepinephrine Bitartrate Injection Usp 3)
This is a description of a medication - Norepinephrine Bitartrate Injection, 4mg per 4ml, to be used for intravenous infusion only. The drug should be diluted before use and any unused portion should be discarded. The medication should be protected from light and proper caution should be exercised to avoid extravasation during administration. The usual dosage should be read in the package insert. The medication should not be used if the solution is pinkish or darker than slightly yellow, or if it contains a precipitate. The medication should be stored in a temperature range of 15-30 degrees Celsius. The distributor of the medication is Hikma Pharmaceuticals USA Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
